Genetically enhanced, cord-blood derived immune cells strike B-cell cancers
Thursday, July 13, 2017 - 11:12
in Biology & Nature
Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers report.